230 related articles for article (PubMed ID: 17477035)
1. Interstitial pneumonitis after combination therapy with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Chen YC; Lu SN; Lin MC
Chang Gung Med J; 2007; 30(1):92-7. PubMed ID: 17477035
[TBL] [Abstract][Full Text] [Related]
2. Interstitial pneumonitis associated with pegylated interferon alpha-2b therapy for chronic hepatitis C: case report.
Carrillo-Esper R; González-Avila D; Uribe-Ríos M; Méndez-Sánchez N
Ann Hepatol; 2008; 7(1):87-90. PubMed ID: 18376374
[TBL] [Abstract][Full Text] [Related]
3. Interstitial pneumonitis during combination therapy with interferon-alpha and ribavirin in a patient with chronic Hepatitis C.
Rothfuss KS; Bode JC
Z Gastroenterol; 2002 Sep; 40(9):807-10. PubMed ID: 12215950
[TBL] [Abstract][Full Text] [Related]
4. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus.
Hashimoto Y; Kanto H; Itoh M
J Dermatol; 2007 Aug; 34(8):577-82. PubMed ID: 17683392
[TBL] [Abstract][Full Text] [Related]
5. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141
[TBL] [Abstract][Full Text] [Related]
6. Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report.
Tamaki K; Okubo A
World J Gastroenterol; 2015 Jan; 21(3):1009-13. PubMed ID: 25624738
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C].
Son BK; Sohn JH; Kim TY; Park YK; Jeon YC; Han DS
Korean J Hepatol; 2007 Mar; 13(1):103-7. PubMed ID: 17380081
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.
Lee SD; Yu ML; Cheng PN; Lai MY; Chao YC; Hwang SJ; Chang WY; Chang TT; Hsieh TY; Liu CJ; Chen DS
J Viral Hepat; 2005 May; 12(3):283-91. PubMed ID: 15850469
[TBL] [Abstract][Full Text] [Related]
9. Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature.
Slavenburg S; Heijdra YF; Drenth JP
Dig Dis Sci; 2010 Mar; 55(3):579-85. PubMed ID: 19399621
[TBL] [Abstract][Full Text] [Related]
10. Taste disturbances during therapy with pegylated interferon-alpha 2b and ribavirin in patients with chronic hepatitis C.
Klimacka-Nawrot E; Musialik J; Suchecka W; Petelenz M; Hartman M; Lichtański P; Błońska-Fajfrowska B
Wiad Lek; 2010; 63(4):289-99. PubMed ID: 21608370
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
Asahina Y; Izumi N; Umeda N; Hosokawa T; Ueda K; Doi F; Tsuchiya K; Nakanishi H; Matsunaga K; Kitamura T; Kurosaki M; Uchihara M; Higaki M; Miyake S
J Viral Hepat; 2007 Jun; 14(6):396-403. PubMed ID: 17501760
[TBL] [Abstract][Full Text] [Related]
12. Life-threatening thrombocytopenia and nephrotic syndrome due to focal segmental glomerulosclerosis associated with pegylated interferon alpha-2b and ribavirin treatment for hepatitis C.
Alves Couto C; Costa Faria L; Dias Ribeiro D; de Paula Farah K; de Melo Couto OF; de Abreu Ferrari TC
Liver Int; 2006 Dec; 26(10):1294-7. PubMed ID: 17105597
[TBL] [Abstract][Full Text] [Related]
13. Comparison of low-dose pegylated interferon versus standard high-dose pegylated interferon in combination with ribavirin in patients with chronic hepatitis C with genotype 3: an Indian experience.
Sood A; Midha V; Hissar S; Kumar M; Suneetha PV; Bansal M; Sood N; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2008 Feb; 23(2):203-7. PubMed ID: 17645472
[TBL] [Abstract][Full Text] [Related]
14. [Respiratory function impairment during treatment of chronic hepatitis C with peginterferon alfa2 and ribavirin. Two cases presentation].
Biedroń-Machura M; Musialik J; Sozańska E; Zbroszczyk M; Baron J; Błońska-Fajfrowska B; Pierzchała W
Wiad Lek; 2012; 65(4):232-8. PubMed ID: 23654144
[TBL] [Abstract][Full Text] [Related]
15. Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.
Derbala M; Amer A; Bener A; Lopez AC; Omar M; El Ghannam M
J Viral Hepat; 2005 Jul; 12(4):380-5. PubMed ID: 15985008
[TBL] [Abstract][Full Text] [Related]
16. Interstitial pneumonitis after treatment for hepatitis C virus infection.
Botnaru V; Munteanu O; Rusu D
Pneumologia; 2015; 64(1):46-50. PubMed ID: 26016056
[TBL] [Abstract][Full Text] [Related]
17. A case of irreversible leukoencephalopathy in a patient with C virus hepatitis treated with pegylated interferon-alpha-2b and ribavirin.
Iacob SA; Petrescu AM; Iacob DG
Rom J Intern Med; 2013; 51(3-4):197-200. PubMed ID: 24620633
[TBL] [Abstract][Full Text] [Related]
18. Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b.
Abergel A; Hezode C; Leroy V; Barange K; Bronowicki JP; Tran A; Alric L; Castera L; Bernard PH; Henquell C; Lafeuille H; Ughetto S; Darcha C; Chevallier M; Martineau N; Dubost S; Randl K; Dhumeaux D; Bommelaer G; Bonny C;
J Viral Hepat; 2006 Dec; 13(12):811-20. PubMed ID: 17109680
[TBL] [Abstract][Full Text] [Related]
19. Interstitial pneumonitis in a patient treated with alpha-interferon and ribavirin for hepatitis C infection.
Karim A; Ahmed S; Khan A; Steinberg H; Mattana J
Am J Med Sci; 2001 Oct; 322(4):233-5. PubMed ID: 11678522
[TBL] [Abstract][Full Text] [Related]
20. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
Kang HM; Park MJ; Hwang JM; Kim JW; Jeong SH
Korean J Hepatol; 2009 Jun; 15(2):209-15. PubMed ID: 19581773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]